ClinicalTrials.gg
Not yet recruitingNCT06277440Updated Feb 26, 2024

Cognitive Training for Attention Deficit Hyperactivity Disorder and Developmental Delays

An interventional study of cognitive training and active control in Attention Deficit Hyperactivity Disorders and Developmental Delays, sponsored by Taipei Medical University. Not yet recruiting at 1 site in Taiwan. Open to participants aged 4 Years to 6 Years. Per ClinicalTrials.gov, last updated 2024-02-26.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
4 Years to 6 Years
Sex
All
01

Study summary

To explore whether children with Attention Deficit Hyperactivity Disorder and developmental delays who receive cognitive training and conventional rehabilitation can improve executive function more than traditional rehabilitation alone. A magnetoencephalographic examination will be arranged to explore how brain network activation works.

Research method: 20 preschool children with Attention Deficit Hyperactivity Disorder and developmental delays under rehabilitation therapy will be collected. They will be randomly assigned to the experimental group (receiving rehabilitation therapy and three times per week for 15 minutes, a total of 12 weeks of interactive cognitive training) and the control group (receiving rehabilitation therapy only). Therapeutic effects will be evaluated.

Read the detailed description

Research method: 20 preschool children with Attention Deficit Hyperactivity Disorder and developmental delays under rehabilitation therapy will be collected. They will be randomly assigned to the experimental group (receiving rehabilitation therapy and three times per week for 15 minutes, a total of 12 weeks of interactive cognitive training) and the control group (receiving rehabilitation therapy only). Therapeutic effects will be evaluated, including Sensory Profile, Swanson, Nolan and Pelham version IV, Conners Kiddie Continuous Performance test, Chinese Childhood Executive Functioning Inventory, and Chinese version of Wechsler Intelligence Scale for Children-IV; and physical health conditions, including Pediatric Daily Occupation Scale, Pediatric Outcome Data Collection Instrument (PODCI), Child Health Questionnaire- Parent Form, Pediatric Quality of Life Inventory (PedsQL)will be evaluated by an investigator who is blinded to the group's allocation at before treatment and after 12 weeks of treatment. All participants will be investigated by magnetoencephalography (MEG) to identify the brain network connectivity while performing different tasks before and after 12 weeks of treatment. Brain Magnetic Resonance Imaging will be performed for brain mapping.

Possible results: The study will shed light on therapeutic effects and brain network connectivity by cognitive training for preschool children with Attention Deficit Hyperactivity Disorder and developmental delays.

02

Conditions studied

  • Attention Deficit Hyperactivity Disorders
  • Developmental Delays

Keywords

  • preschool children
  • developmental delay
  • cognitive training
  • attention deficit hyperactivity disorder
03

In context

Attention Deficit Disorder with Hyperactivity

1,817 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 296 are open to participants now.

This study's planned enrollment of 20 is below the median of 71 across 1,437 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Taipei Medical University is the lead sponsor of 257 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • preschool children with Attention Deficit Hyperactivity Disorder and developmental delays under regular rehabilitation programs intelligence quotient 70 or greater

Exclusion criteria

Exclusion Criteria:

  • age less than 4 or greater than 6 metal in teeth intelligence quotient less than 70
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Traditional rehabilitation program with additional cognitive training

    Other: cognitive training

  • Other
    Active Control

    Traditional rehabilitation programs without additional cognitive training

    Other: active control

Interventions

  • Othercognitive training

    cognitive training, 15 min, three times per week, for 12 weeks

    Also known as: traditional rehabilitation programs

  • Otheractive control

    Traditional rehabilitation programs

    Also known as: traditional rehabilitation programs

06

What researchers measure

Primary outcomes

  1. Changes of executive function

    Changes in scores assessed by the Taiwanese Traditional Chinese Childhood Executive Functioning Inventory range from 1 to 5, higher scores indicate a worse outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

Secondary outcomes

  1. changes of symptoms of attention deficit hyperactivity disorder

    Changes in scores assessed by Swanson, Nolan and Pelham questionnaire, range from 0 to 54, higher scores indicate a worse outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

  2. changes of attention

    Changes in scores assessed by Conners Kiddie Continous Performance Test, range from 0-100, higher scores indicate a worse outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

  3. Changes of sensory integration

    Changes in scores assessed by Sensory Profile, range from 0-100, higher scores indicate a better outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

  4. changes of intelligence

    Changes in scores assessed by the Wechsler Intelligence Scale of children, the average score is 100, with a higher score indicating higher intelligence and a lower score indicating a lower level of intelligence.

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

  5. changes of functional performance

    Changes in scores assessed by Pediatric Outcome Data Collection Instrument, range from 0-100, higher scores indicate a better outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

  6. Changes of family impact

    Changes in scores assessed by Child Health Questionaire, parent form 28, range from 0-100, higher scores indicate a better outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

  7. Changes of quality of life

    Changes in scores assessed by Pediatric Quality of Life Inventory, range from 0-100, higher scores indicate a better outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

  8. Changes in performance activity in kindergarten

    Changes in scores assessed by Kindergarten Performance Activity, range from 0-100, higher scores indicate a worse outcome

    Time frame: score change from baseline to 12 weeks of treatment, higher score, the better outcome

Other outcomes

  1. changes of brain network connectivity

    Changes of brain network connectivity assessed by magnetoencephalography, range from 0-1, higher scores indicate a better outcome

    Time frame: connectivity change from baseline to 12 weeks of treatment, higher score, the better outcome

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2024; primary completion for Sep 2024, 6 months later.

Of 479 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 6 months is below that.

Counting every sponsor, half of 510 studies reached it within 23 months; a quarter within 11 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 5, 2024
First posted
Feb 26, 2024
StartEst.
Mar 1, 2024
Primary completionEst.
Sep 30, 2024
CompletionEst.
Sep 30, 2024
Last update
Feb 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06277440
Responsible party
Sponsor
First posted
Feb 26, 2024
Start date
Mar 1, 2024 (estimated)
Primary completion
Sep 30, 2024 (estimated)
Completion
Sep 30, 2024 (estimated)
Last update
Feb 26, 2024

Study contacts

Ru-Lan Hsieh, MD, MD
Contact
M001052@ms.skh.org.tw
886-2-28332211 ext. 2538, 2531
Ru-Lan Hsieh, MD, MD
Contact
rulanhsieh@gmail.com
Ru-Lan Hsieh, MD
principal investigator · Shin Kong Wu Ho-Su Memorial Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion